Advertisement

Codiak BioSciences, Inc. CDAK

Set alert

Price alert · CDAK

All alert types
0.06 +0.06 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
0
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
0.00
Beta
0.00
Dividend
0.00
Ex-div date
Earnings
May 4, 2023
50-d avg
0.00
200-d avg
0.00
1y target
9.00

1M chart

Chart tools
Interval

Events in this range
  • May 4, 2023Earnings: —; estimate 0; surprise —%
Signals (3)
NameDateAgo
SMA: BullishMay 23, 20233 years ago
SMA: BearishMay 22, 20233 years ago
SMA: BullishMay 5, 20233 years ago

Key statistics

Market cap
0
Trailing P/E
0.00
Forward P/E
0.00
Price / sales
0.00
Beta
0.00
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
0
Total cash
0
Total debt
0
Return on equity
0.00%
50-day average
0.00
200-day average
0.00

Analyst view

Consensus: buy

Buy
Price target (mean) 9.00

Next earnings

May 4, 2023

Expected May 4, 2023. Consensus EPS estimate -0.36.

Earnings history

Earnings

CDAK recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
May 4, 2023Mar 1, 20230.00———
Nov 3, 2022Sep 1, 2022-0.82———
Aug 4, 2022Jun 1, 2022-0.78———
May 5, 2022Mar 1, 2022-0.80———
Mar 10, 2022Dec 1, 2021-1.03———

Upgrades / downgrades

CDAK analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2022Goldman Sachsmain—Neutral
Aug 31, 2022Goldman SachsdownBuyNeutral
Jul 4, 2022Goldman Sachsmain—Buy
May 23, 2022Goldman Sachsmain—Buy
Feb 21, 2022Wedbushmain—Outperform
Feb 10, 2022Goldman Sachsinit—Buy

News

Your note

Sign in to keep a note on CDAK — it syncs with the Stock Master app.

Insider holders

CDAK insider holders
InsiderRelationLatest transactionDateShares held
BAIN LINDA CChief Financial OfficerSaleMar 27, 20230
BARNA NICOLEOfficerSaleMar 28, 20234,849
BERNSTEIN KARENDirectorConversion of Exercise of derivative securityFeb 15, 20230
COONEY CHARLES LDirectorConversion of Exercise of derivative securityFeb 15, 20238,750
GILLIS STEVENDirectorConversion of Exercise of derivative securityFeb 15, 20238,750
HOWZE YALONDAOfficerSaleMar 29, 20237,458

Institution ownership

CDAK institution ownership
Holder% heldSharesValueReported
FMR, LLC12.51%4,605,5931.83MDec 30, 2022
Flagship Pioneering Inc.9.61%3,540,6361.41MDec 30, 2022
Laurion Capital Management, LP5.47%2,013,300800.49KDec 30, 2022
University of Texas/Texas AM Investment Managment Co2.30%847,108336.81KDec 30, 2022
Vanguard Group, Inc. (The)2.24%823,736327.52KDec 30, 2022
Alyeska Investment Group, L.p.1.81%666,891265.15KDec 30, 2022

Fund ownership

CDAK fund ownership
Holder% heldSharesValueReported
Fidelity Growth Company Fund4.00%1,474,2591.02MNov 29, 2022
Vanguard Total Stock Market Index Fund1.50%552,448432.01KSep 29, 2022
Fidelity Select Portfolios - Biotechnology1.22%448,539309.54KNov 29, 2022
Fidelity Series Growth Company Fund1.18%432,962298.79KNov 29, 2022
Fidelity Growth Company K6 Fund1.05%386,380266.64KNov 29, 2022
Vanguard Extended Market Index Fund0.64%236,468184.92KSep 29, 2022
Advertisement